Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Boehringer Ingelheim
McKinsey
McKesson
Colorcon

Last Updated: February 7, 2023

CLINICAL TRIALS PROFILE FOR ADASUVE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Adasuve

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00444028 ↗ Staccato Loxapine Single Dose PK Completed Alexza Pharmaceuticals, Inc. Phase 1 2005-09-01 The objective of this study was to assess the safety, tolerability and pharmacokinetics of a single inhaled dose of (administered in 1 or 2 puffs) Staccato Loxapine in healthy volunteers.
NCT00489476 ↗ Staccato Loxapine in Migraine (in Clinic) Completed Alexza Pharmaceuticals, Inc. Phase 2 2007-06-01 The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting.
NCT00543062 ↗ Staccato Prochlorperazine Thorough QT/QTc Completed Alexza Pharmaceuticals, Inc. Phase 1 2007-10-01 To assess the safety of Staccato Prochlorperazine on cardiac repolarization (QTc interval duration) at 2 dose levels compared to placebo in healthy volunteers.
NCT00628589 ↗ Staccato Loxapine in Agitated Patients With Schizophrenia Completed Alexza Pharmaceuticals, Inc. Phase 3 2008-02-01 Phase 3 safety and efficacy study of Staccato Loxapine in the treatment of acute agitation in schizophrenic patients
NCT00825500 ↗ Staccato Loxapine in Migraine (Out Patient) Completed Alexza Pharmaceuticals, Inc. Phase 2 2009-01-01 Assess the safety and efficacy of Staccato Loxapine in patients with moderate to severe migraine headache with or without aura in an outpatient setting.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Adasuve

Condition Name

Condition Name for Adasuve
Intervention Trials
Migraine 2
Agitation,Psychomotor 2
Schizophrenia 2
Healthy Volunteers 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Adasuve
Intervention Trials
Psychomotor Agitation 4
Schizophrenia 3
Migraine Disorders 2
Headache 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Adasuve

Trials by Country

Trials by Country for Adasuve
Location Trials
United States 13
Netherlands 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Adasuve
Location Trials
Indiana 4
Georgia 2
Arkansas 1
Ohio 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Adasuve

Clinical Trial Phase

Clinical Trial Phase for Adasuve
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
Phase 2 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Adasuve
Clinical Trial Phase Trials
Completed 11
Terminated 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Adasuve

Sponsor Name

Sponsor Name for Adasuve
Sponsor Trials
Alexza Pharmaceuticals, Inc. 9
Teva Branded Pharmaceutical Products R&D, Inc. 1
Teva Branded Pharmaceutical Products, R&D Inc. 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Adasuve
Sponsor Trials
Industry 12
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Johnson and Johnson
Colorcon
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.